{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:19:04Z","timestamp":1788211144245,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017981","name":"Sysmex Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.brainres.2026.150259","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:19:42Z","timestamp":1773188382000},"page":"150259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A fully automated immunoassay for plasma kallikrein-8: Development and evaluation in mild cognitive impairment"],"prefix":"10.1016","volume":"1881","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1080-0764","authenticated-orcid":false,"given":"Ishita","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-4944","authenticated-orcid":false,"given":"Masahiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Shiosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2026.150259_b0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.brainres.2026.150259_b0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature09938","article-title":"Neuropsin cleaves EphB2 in the amygdala to control anxiety","volume":"473","author":"Attwood","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2026.150259_b0015","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2026.150259_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00014168","article-title":"Neuropathology of Alzheimer's disease: what is new since a. Alzheimer?","volume":"249","author":"Braak","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainres.2026.150259_b0025","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2026.150259_b0030","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1523\/JNEUROSCI.15-07-05088.1995","article-title":"Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus","volume":"15","author":"Chen","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2026.150259_b0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/pn-2023-003988","article-title":"Pathology of neurodegenerative disease for the general neurologist","volume":"24","author":"Cullinane","year":"2024","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.brainres.2026.150259_b0040","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia: a population-based cohort study","volume":"143","author":"De Wolf","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2026.150259_b0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1074\/jbc.M110.125310","article-title":"Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade","volume":"286","author":"Eissa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2026.150259_b0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2026.150259_b0055","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2026.150259_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"Gotz","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.brainres.2026.150259_b0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/nan.12687","article-title":"Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer\u2019s pathology in mice","volume":"47","author":"Herring","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.brainres.2026.150259_b0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jalz.2016.05.006","article-title":"Kallikrein-8 inhibition attenuates Alzheimer\u2019s disease pathology in mice","volume":"12","author":"Herring","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2026.150259_b0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1523-1747.1998.00212.x","article-title":"Expression of neuropsin in the keratinizing epithelial tissue-immunohistochemical analysis of wild-type and nude mice","volume":"110","author":"Inoue","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.brainres.2026.150259_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2026.150259_b0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2026.150259_b0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2026.150259_b0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainres.2026.150259_b0100","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1074\/jbc.M607998200","article-title":"Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins","volume":"282","author":"Kishibe","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2026.150259_b0105","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1038\/s41598-018-27640-6","article-title":"A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling","volume":"8","author":"Konar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2026.150259_b0110","doi-asserted-by":"crossref","unstructured":"Krizanovic, N., Jokisch, M., J\u00f6ckel, K.-H., Schmidt, B., Stang, A., and Schramm, S. Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study, 2024. J. Alzheimer'sDis.100, 495-507. https:\/\/doi.org\/10.3233\/JAD-24004.","DOI":"10.3233\/JAD-240045"},{"key":"10.1016\/j.brainres.2026.150259_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-015-0124-3","article-title":"Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer\u2019s disease patients and healthy controls","volume":"7","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.brainres.2026.150259_b0120","first-page":"1997","article-title":"The association of serum Kallikrein-8 with cognitive function in vascular dementia","volume":"25","author":"Li","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2026.150259_b0125","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.23-21-07727.2003","article-title":"NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin","volume":"23","author":"Matsumoto-Miyai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2026.150259_b0130","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.brainres.2026.150259_b0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2026.150259_b0140","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2026.150259_b0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1532-5415.5155.x","article-title":"Vascular dementia: distinguishing characteristics, treatment, and prevention","volume":"51","author":"Roman","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.brainres.2026.150259_b0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/ADR-220073","article-title":"Blood Kallikrein-8 and non-amnestic mild cognitive impairment: an exploratory study","volume":"7","author":"Schramm","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.brainres.2026.150259_b0155","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1097\/00001756-200108280-00031","article-title":"Expression of the kallikrein gene family in normal and Alzheimer\u2019s disease brain","volume":"12","author":"Shimizu-Okabe","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2026.150259_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104774","article-title":"Kallikrein 8: a key sheddase to strengthen and stabilize neural plasticity","volume":"140","author":"Shiosaka","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2026.150259_b0165","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mp.2011.147","article-title":"The neuropathological profile of mild cognitive impairment (MCI): a systematic review","volume":"17","author":"Stephan","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2026.150259_b0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuint.2017.12.002","article-title":"Trophic modulation of gamma oscillations: the key role of processing protease for Neuregulin-1 and BDNF precursors","volume":"119","author":"Tamura","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2026.150259_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jnnp-2019-321073","article-title":"CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer\u2019s disease","volume":"91","author":"Teuber-Hanselmann","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2026.150259_b0180","unstructured":"World Health Organization, 2023. Dementia. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia (accessed 15 January 2025)."},{"key":"10.1016\/j.brainres.2026.150259_b0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-023-05800-5","article-title":"Upregulation of KLK8 contributes to CUMS-induced hippocampal neuronal apoptosis by cleaving NCAM1","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2026.150259_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158708","article-title":"Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"132","author":"Zhao","year":"2022","journal-title":"J. Clin. Invest."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899326001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:35:55Z","timestamp":1788208555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899326001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S0006899326001186"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150259","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fully automated immunoassay for plasma kallikrein-8: Development and evaluation in mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2026.150259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150259"}}